Abstract:Endometriosis is an estrogen-dependent gynecologic disease, which is characterized by the elevated ratio of ERβ/ERα expression. Retrograde menstruation leads to ectopic erythrocytes deposition and iron overload at pelvic cavity in endometriosis. Lipocalin 2 (LCN2) is a secretory protein that plays important role during iron transport and metabolism. To date, the relationship of estrogen and iron homeostasis is not well studied yet. The aim of our study was to investigate the role of estrogen in regulating iron metabolism in endometriosis. Sixty-eight women with endometriosis and forty-three women without endometriosis (controls) were included, and their serum levels of estrodiol and LCN2 were determined for via ELISA. Primary cultures of ESCs were obtained in vitro. The expression of estrogen receptor (ER) α, ERβ, and LCN2 was examined by qPCR, western blot, and ELISA. ChIP was used to investigate how ER regulated LCN2. Cell viability was assessed by Cell Counting Kit-8 assay. Reactive oxygen species production was evaluated by dihydroethidium staining. In addition, the intracellular ferrous iron level (Fe2+ ) were examined using an iron assay kit. Ferroptosis was evaluated by Cyclooxygenase-2(COX-2), Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4), glutathione peroxidase 4 (GPX4) and ferritin heavy chain 1(FTH1). Elevated serum LCN2 levels were found in women with endometriosis compared to those without. A positive correlation of E2 and LCN2 was observed in endometriosis group but not in controls. E2 dose-dependently increased the LCN2 expression in ESCs. This was also seen in the presence of ERα antagonist alone but not with ERβ antagonist alone. Interestingly, ERα bind to LCN2 promoter and attenuated the expression of LCN2. Moreover, E2-induced LCN2 expression resulted increased intracellular iron concentrations. Importantly, LCN2 attenuated GPX4 and FTH1 expression, increased COX-2 and ACSL4 levels, which in turn inhibited the ferroptosis of ESCs. This ferroptosis inhibition effect can also be partly reversed by the inhibition of ERβ or overexpression of ERα. Our studies demonstrate that upregulated E2 may inhibit ferroptosis via ERβ/ERα/ LCN2 pathway, potentially resulted in endometriotic tissue survival and progression, ERβ/ERα/LCN pathway may be a potential target for endometriosis treatment.

Back Cover: The PES1/FOXM1 heterodimer suppresses TCF21 and ERβ expression in ovarian endometriosis (View 1/2024)

Overexpressed Mps-1 Contributes To Endometrioma Development Through The Nf-Kappa B Signaling Pathway

Overexpressed MPS-1 contributes to endometrioma development through the NF-κB signaling pathway

CTHRC1 Overexpression Promotes Ectopic Endometrial Stromal Cell Proliferation, Migration and Invasion Via Activation of the Wnt/β-catenin Pathway

PES1 Promotes Breast Cancer by Differentially Regulating ERα and ERβ

LncRNA MEG3-210 Regulates Endometrial Stromal Cells Migration, Invasion and Apoptosis Through P38 MAPK and PKA/SERCA2 Signalling Via Interaction with Galectin-1 in Endometriosis.

Osteopontin Regulates Endometrial Stromal Cell Migration in Endometriosis Through the PI3K Pathway

Abstract #1504468: Estrogen Attenuates Ferroptosis Via Estrogen Receptor (ER) Β/erα/lipocalin 2 Pathway in Endometriosis

Hypoxia Promotes Ectopic Adhesion Ability of Endometrial Stromal Cells Via TGF-β1/Smad Signaling in Endometriosis

Transcription factor 21 regulates expression of ERβ and SF-1 via upstream stimulatory factor-2 in endometriotic tissues.

Transcription Factor 21 Regulates Estrogen Receptor-Beta and Steroidogenic Factor-1 Expression Via Upstream Stimulatory Factor-2 in Endometriosis.

17Βe2 Promotes Cell Proliferation in Endometriosis by Decreasing PTEN Via NFκB-dependent Pathway

FoxA2 represses ERβ-mediated pyroptosis in endometriosis by transcriptionally inhibiting IGF2BP1

ERβ-activated LINC01018 promotes endometriosis development by regulating the CDC25C/CDK1/CyclinB1 pathway

High Expression Of Zeb1 In Endometriosis And Its Role In 17 Beta-Estradiol-Induced Epithelial- Mesenchymal Transition

Follicular Fluid Progesterone Downregulated HPGD and COX2 in Granulosa Cells Via Suppressing NF-ĸB in Endometriosis

Silencing of Forkhead Box M1 Reverses Transforming Growth Factor-β1-Induced Invasion and Epithelial-Mesenchymal Transition of Endometriotic Epithelial Cells

Estrogen Receptor Beta Promotes Endometriosis Progression by Upregulating CD47 Expression in Ectopic Endometrial Stromal Cells.

Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma

Repression of FBXW7 by HES5 contributes to inactivation of the TGF-β signaling pathway and alleviation of endometriosis.

Inhibitory effects of silencing PES1 gene expression on the malignant phenotypes of colon cancer cells